Fischer Medical Ventures Q2 Results 2026: PAT ₹1 Cr (−94.2% YoY)
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
- Revenue
- ₹107Cr
- +24.5% YoY
- +31.2% QoQ
- Net profit
- ₹1Cr
- −94.2% YoY
- −78.9% QoQ
- Margin
- 8.3%
- −10.5 pp YoY
- −5.4 pp QoQ
Guidance rank: #10 of 13 in Healthcare Equipment & Supplies
See the sector's top 10 — free with your mobile number.
Fischer Medical Ventures Ltd Q2 FY27 key numbers
- Revenue
- Other income in standalone increased substantially to ₹3,037.72 Lakhs from ₹143.46 Lakhs the previous year.
As stated in Fischer Medical Ventures Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.
Based on Fischer Medical Ventures Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
For the quarter ended September 30, 2026, the Standalone revenue from operations was ₹27.62 Lakhs compared to ₹742.69 Lakhs in Q2 FY 2025, showing a significant year-on-year decline. EBITDA for the quarter ended 30 September 2026: Rs. 2,815.94 lakhs (Consolidated).
From Fischer Medical Ventures Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Fischer Medical Ventures' revenue grow in the September 2026 quarter?
- For the quarter ended September 30, 2026, the Standalone revenue from operations was ₹27.62 Lakhs compared to ₹742.69 Lakhs in Q2 FY 2025, showing a significant year-on-year decline.
- Consolidated revenue from operations for the same quarter was ₹10,743.65 Lakhs versus ₹8,629.52 Lakhs in Q2 FY 2025, indicating a year-on-year increase.
- Other income in standalone increased substantially to ₹3,037.72 Lakhs from ₹143.46 Lakhs the previous year.
- Adjustments were made to past period comparative figures due to audit revisions for foreign subsidiaries, but these did not impact annual profit or reserves.
What happened to Fischer Medical Ventures' margins in Q2 FY27?
EBITDA for the quarter ended 30 September 2026: Rs. 2,815.94 lakhs (Consolidated)
Locked: what Fischer Medical Ventures Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Fischer Medical Ventures planning?
See what Fischer Medical Ventures Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Fischer Medical Ventures raising money or cutting debt?
The Board approved allotment of equity shares through conversion of convertible warrants on 11, 12, 13,…
Locked: what Fischer Medical Ventures Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
How big is Fischer Medical Ventures' order book?
See what Fischer Medical Ventures Ltd said on order book & pipeline — free account, 30 seconds.
Fischer Medical Ventures Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the table below.
Fischer Medical Ventures Ltd Q2 FY27 results — key figures
| ₹ Cr | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Revenue | 107 | 86 | +24.5% | 82 | +31.2% |
| Operating profit (EBITDA) | 9 | 16 | -45% | 11 | -20.5% |
| Operating margin | 8.3% | 18.8% | -10.5 pp | 13.7% | -5.4 pp |
| Profit before tax | 9 | 17 | -49.4% | 8 | +11.7% |
| Net profit (PAT) | 1 | 14 | -94.2% | 4 | -78.9% |
| EPS (₹) | 0.01 | 2.15 | -99.5% | 0.06 | -83.3% |
Source: Fischer Medical Ventures Ltd's results filing to NSE (consolidated), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹82 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →More Q2 FY27 results in Healthcare Equipment & Supplies
- Molbio Diagnosti Q2 FY27 results
- Poly Medicure Q2 FY27 results
- Sahajanand Medi Q2 FY27 results
- Tarsons Products Q2 FY27 results
- Laxmi Dental Q2 FY27 results
- Vasa Denticity Q2 FY27 results
- OSEL Devices Q2 FY27 results
- QMS Medical Q2 FY27 results
All Q2 FY27 results | Healthcare Equipment & Supplies rankings
Continue your research
What Fischer Medical's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Mohini Health (Q2 FY27)
Revenue from operations for the half year ended 30th Sept 2026 is ₹11,043.00 lakhs, compared to ₹7,353.87 lakhs for the half year ended 30th Sept 2025, showing…
- Aprameya Enginee (Q2 FY27)
216.21 lakhs, up 97% year-on-year (YoY). Key results statement takeaways from Aprameya Engineering Ltd's Q2 FY27 results statement — and how it ranks against se
- QMS Medical (Q2 FY27)
4,470.00 lakhs in Q2 2025), a year-on-year increase of approximately 17.5% . Key results statement takeaways from QMS Medical Allied Services Ltd's Q2 FY27 resu
- OSEL Devices (Q2 FY27)
31.8% increase ((19,363.37 . Key results statement takeaways from OSEL Devices Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fischer Medical Ventures Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fischer Medical Ventures Ltd Q2 FY27 results?
For the quarter ended September 30, 2026, the Standalone revenue from operations was ₹27.62 Lakhs compared to ₹742.69 Lakhs in Q2 FY 2025, showing a significant year-on-year decline. EBITDA for the quarter ended 30 September 2026: Rs. 2,815.94 lakhs (Consolidated).
What is Fischer Medical Ventures Ltd share price analysis?
Fischer Medical Ventures Ltd currently shows a neutral. The stock trades at a P/E of 70.9 with a market cap of ₹1,735 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Fischer Medical Ventures Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.